Using proteins to prevent and treat Alzheimer's disease and aging-related conditions
Harnessing Proteins as Drugs: the Protectome of Cancer- and Aging-Prevention Proteins
This study is exploring how we can boost our body's natural proteins to help keep our cells healthy and potentially prevent diseases like Alzheimer's, making it a hopeful option for anyone concerned about age-related health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11015370 on NIH RePORTER |
What this research studies
This research investigates how proteins can be harnessed to improve cellular health and prevent diseases like Alzheimer's. It focuses on enhancing the body's natural proteins that protect against DNA damage and misfolded proteins, which are linked to Alzheimer's disease. By upregulating these protective proteins, the research aims to create a new class of treatments that could help maintain cellular stability and prevent age-related diseases. The approach involves advanced technologies to identify and utilize these proteins effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease or those experiencing early signs of cognitive decline.
Not a fit: Patients with advanced Alzheimer's disease or those with other unrelated severe cognitive impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that prevent or slow the progression of Alzheimer's disease and other age-related conditions.
How similar studies have performed: Other research has shown promise in using proteins for therapeutic purposes, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Rosenberg, Susan M — Baylor College of Medicine
- Study coordinator: Rosenberg, Susan M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.